SearchDictionaryMobileLogin

Dianne Tomita Selected Research

Anemia

06/2008Treating Anemia of Cancer with Every-4-Week Darbepoetin Alfa: Final Efficacy and Safety Results from a Phase II, Randomized, Double-Blind, Placebo-Controlled Study.
10/2007A randomized, open-label, multicenter trial of immediate versus delayed intervention with darbepoetin alfa for chemotherapy-induced anemia.
06/2007Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: a controlled, randomized, open-label phase II trial.
05/2007The effectiveness of darbepoetin alfa administered every 3 weeks on hematologic outcomes and quality of life in older patients with chemotherapy-induced anemia.
05/2006Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial.
04/2006Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia.
12/2005Treatment of chemotherapy-induced anemia in breast cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40,000 U weekly.
01/2004A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer.
11/2003A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia.
07/2003Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks.
10/2002Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.

Articles by Research Topic

Disease

11Anemia
06/2008 - 10/2002
4Neoplasms (Cancer)
06/2008 - 07/2003
1Breast Neoplasms (Breast Cancer)
12/2005
1Fatigue
07/2003
1Lung Neoplasms (Lung Cancer)
08/2002

Drug/Important Bio-Agent (IBA)

12darbepoetin alfa (Aranesp)FDA Link
06/2008 - 08/2002
4Epoetin Alfa (Epogen)FDA Link
05/2006 - 11/2003

Therapy/Procedure

10Drug Therapy (Chemotherapy)
10/2007 - 08/2002